For the quarter ending 2026-03-31, NVCR had -$6,066K decrease in cash & cash equivalents over the period. -$18,669K in free cash flow.
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net income (loss) | -71,138 | -24,499 | -37,270 | -74,458 |
| Depreciation and amortization | 4,124 | 4,218 | 3,663 | 6,769 |
| Accrued interest | -219 | 513 | 789 | 3,647 |
| Asset write-downs and impairment of field equipment | 712 | 1,936 | 230 | 2,685 |
| Share-based compensation | 63,009 | 19,816 | 29,321 | 55,695 |
| Foreign currency remeasurement loss (gain) | -477 | 961 | -890 | -1,322 |
| Decrease (increase) in accounts receivables and prepaid expenses | -828 | 23,462 | -3,577 | 19,053 |
| Amortization of discount (premium) | -2,617 | -3,746 | -6,402 | -13,114 |
| Decrease (increase) in inventories | 2,778 | 1,984 | -886 | 4,570 |
| Decrease (increase) in other long-term assets | -2,042 | -4,367 | -2,490 | -3,990 |
| Increase (decrease) in accounts payables and accrued expenses | -5,120 | 8,441 | 24,830 | -14,313 |
| Increase (decrease) in other long-term liabilities | -2,837 | -2,643 | -2,430 | -201 |
| Net cash provided by (used in) operating activities | -13,517 | -18,004 | 20,574 | -51,601 |
| Purchase of property, equipment and field equipment | 5,152 | 4,896 | 5,655 | 16,097 |
| Proceeds from maturity of short-term investments | 110,000 | 560,000 | 185,000 | 540,000 |
| Purchase of short-term investments | 97,101 | 218,778 | 107,909 | 494,389 |
| Net cash provided by (used in) investing activities | 7,747 | 336,326 | 71,436 | 29,514 |
| Proceeds from issuance of shares, net | 0 | 1,520 | 0 | 2,136 |
| Proceeds from senior secured credit facility, net | 0 | 0 | 99,979 | 0 |
| Repayment and redemption of long-term debt | 0 | 560,945 | 0 | 0 |
| Tax payments related to net settlements on equity awards | 556 | 146 | - | - |
| Exercise of options | 390 | 77 | 538 | 5,498 |
| Net cash provided by (used in) financing activities | -166 | -559,494 | 100,517 | 7,634 |
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | -130 | -76 | -22 | 492 |
| Increase (decrease) in cash, cash equivalents and restricted cash | -6,066 | -241,248 | 192,505 | -13,961 |
| Cash, cash equivalents and restricted cash at the beginning of the period | 103,390 | 344,638 | 166,094 | - |
| Cash, cash equivalents and restricted cash at the end of the period | 97,324 | 103,390 | 344,638 | - |
NovoCure Ltd (NVCR)
NovoCure Ltd (NVCR)